Health informatics firm Allostatix LLC will host a webinar titled Predicting Future Wellness: Improving Employee Health and Cost Savings (http://www.hr.com/stories/1215803933168), on Wednesday, July 30 at 1-2 p.m. Eastern time.
A healthy workforce benefits employers with decreased absenteeism; happier, more productive employees; and better control over rising healthcare benefits costs. Yet most existing health
risk assessments (http://www.hr.com/stories/1215803933168) miss a critical segment of the employee population - those without visible
indicators of illness who are on a negative health trajectory by their reaction to accumulating stress.
Gordon Horwitz, founder and chief executive officer of Cincinnati startup Allostatix, LLC, will discuss how this accumulated stress - a person's allostatic load - is a reliable predictor
of health problems in the near future.
"The common assumption is that employees with normal test levels and negative medical history are therefore "healthy" and "low-risk," said Horwitz. "However, testing for the allostatic
load provides a picture of "whole body health" - a much more accurate approach than self-reported health behaviors or isolated tests that do not provide a comprehensive picture of
health."
This webinar examines how the daily stresses of life can build up over time and lead to expensive medical problems, and how a new test can actually predict future health status with over
80 percent accuracy. Participants will learn:
- The concept and background of allostatic load
- How stress affects overall health
- What most health risk assessments miss
- How predicting wellness can save an organization money
To sign up for the complementary webinar, visit http://www.hr.com/stories/1215803933168
About Allostatix, LLC.
Allostatix LLC is the creator of the Allostatix Load Test, a scientific tool that measures the cumulative impact of daily life stresses on an individual's whole body health. The company's
predictive measurement is conducted through a blood and biometric analysis and is based on 25 years of longitudinal medical research. Allostatix's Scientific Advisory Board consists of
industry-leading research MDs and PhDs from UCLA, Rockefeller University, the University of Pittsburgh and the University of Cincinnati.
More information is available at http://www.allostatix.com or via e-mail at getanswers(at)allostatix.com.
Contact:
Gordon Horwitz
Allostatix, LLC
513-351-0368
Gail DeLano
Fisher Vista for Allostatix
gdelano(at)fishervista.com
831-685-9700
This press release was distributed through eMediawire by Human Resources Marketer (HR Marketer: www.HRmarketer.com) on behalf of the company
listed above.